GLP-1 Therapy Support Stack — Stacking Protocols
Reduce GLP-1-induced nausea, constipation, and GI side effects
Overview
This protocol combines BPC-157 for reduce glp-1-induced nausea, constipation, and gi side effects. Originally from the Gut category.
Indications
- Reduce GLP-1-induced nausea, constipation, and GI side effects
- Synergistic peptide combination therapy
- Multi-pathway optimization
Mechanism of Action
Reduce GLP-1-induced nausea, constipation, and GI side effects
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| BPC-157 | See dosing notes | As per protocol | Follow detailed dosing schedule below |
Evidence Grade
GRADE D
Safety & Contraindications
- Requires physician supervision for peptide stacking
- Monitor for additive or synergistic side effects
- Follow individual peptide safety guidelines for each component
- Use sterile technique for all injections
- Consult healthcare provider before combining multiple peptides